Bausch Health Companies Inc

Financials

Genel Bakış Tablolar İstatistikler Temettüler

İşletme faaliyetlerinden elde edilen nakit 601 M211 M289 M405 M495 M 1.4 B Yatırım faaliyetlerinden elde edilen nakit -200 M-130 M-100 M-83 M-282 M -595 M Finansman faaliyetlerinden elde edilen nakit 85 M-146 M358 M-719 M-235 M -742 M Free cash flow 494 M87 M189 M314 M403 M 993 M

Bausch Health Companies Inc. is a global, diversified Canadian pharmaceutical company. Its global corporate headquarters are located in Laval, Quebec, Canada, and its U.S. headquarters are in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neuroscience, dermatology, dentistry, medical aesthetics, and international pharmaceuticals. Bausch Health manufactures and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America.

BHC

Financials

Bausch Health Companies Inc

Haberler

Tracking John Paulson’s Paulson & Company Portfolio – Q4 2025 Update

Bausch Health, 2023 PSU’ları nakit olarak ödeyecek

Bausch Health updates executive compensation agreements to cash settlement for 2023 PSUs

Oruka Therapeutics: A Potential Future Psoriasis Play (NASDAQ:ORKA)

Ironwood vs. Bausch Health: Which GI Drug Stock is a Better Pick Now?

Canada stocks higher at close of trade; S&P/TSX Composite up 0.61%

BHC Stock Down on Q4 Earnings Miss, Salix Drives Revenue Growth

How Bausch Health’s Turnaround Progressed In Q4 2025 (NYSE:BHC)

Bausch Health Companies Inc. 2025 Q4 - Results - Earnings Call Presentation (NYSE:BHC) 2026-02-19

Bausch Health Companies Inc. (BHC) Q4 2025 Earnings Call Transcript

Here's What Key Metrics Tell Us About Bausch (BHC) Q4 Earnings

Bausch Health (BHC) Q4 Earnings Lag Estimates